Evofem Biosciences, Inc.
For the period ended Sep 17, 2026. Filed Sep 23, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Sep 17, 2026 · Filed Sep 23, 2026
Use the contents to explore the available documents and sections.
EVFM$0.48-23.4%Stored close · as of Aug 10, 2022
Contents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.